Items in cart [0] Questions? Call 888-624-8373

PAPERBACK list:$58.25 Web:$52.43 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles Preventing Medication Errors: Quality Chasm Series The Learning Healthcare System: Workshop Summary (IOM Roundtable on Evidence-Based Medicine) Other Related Titles Description and Analysis of the VA National Formulary (2000) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 217   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Acronyms AAHP American Association of Health Plans ACCP American College of Clinical Pharmacy ACEI angiotensin-converting enzyme inhibitor ACP American College of Physicians ADE adverse drug event ADR adverse drug reaction AFDC Aid to Families with Dependent Children AMA American Medical Association AHA American Hospital Association AMCP Academy of Managed Care Pharmacy AMP average manufacturer price APhA American Pharmaceutical Association ASHP American Society of Health-System Pharmacists AWP average wholesale price BCF Basic Core Formulary BPA blanket purchase agreement CCB calcium channel blocker CHAMPUS Civilian Health and Medical Programs of the Uniformed Services CMOP consolidated mail outpatient pharmacy COPD chronic obstructive pulmonary disease COX-2 cyclooxygenase-2 Page 217 Front Matter (R1-R18) Executive Summary (1-10) Introduction (11-36) Is the VA National Formulary Overly Restrictive and Does it Prevent Physicians from Meeting the Health Care Needs of Veterans? (37-71) What are the Potential Costs to VA Health Care Associated with the National Formulary for Drugs? (72-119) What are the Effects of the National Formulary and Related Policies on Quality of Care? (120-148) How Does the VA National Formulary Compare with Private Insurance Formularies for Drugs and Devices and with Other Government Formularies? (149-182) The VA National Formulary and Veterans Health Care (183-200) References (201-216) Acronyms (217-220) Appendix A: Interim Report of the Committee on VA Pharmacy Formulary Analysis to the Department of Veterans Affairs and the Congress of the United States (221-226) Appendix B: Academy of Managed Care Pharmacy's Managed Care Formulary and Pharmacy Benefit Design Survey (227-230) Appendix C: Additional Cost Information (231-249) Appendix D: Glossary (250-253) Appendix E: Drug Classes and Drug Index (254-258) Appendix F: Committee Biographies (259-262)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 217
DESCRIPTION AND ANALYSIS OF THE VA National Formulary Acronyms AAHP American Association of Health Plans ACCP American College of Clinical Pharmacy ACEI angiotensin-converting enzyme inhibitor ACP American College of Physicians ADE adverse drug event ADR adverse drug reaction AFDC Aid to Families with Dependent Children AMA American Medical Association AHA American Hospital Association AMCP Academy of Managed Care Pharmacy AMP average manufacturer price APhA American Pharmaceutical Association ASHP American Society of Health-System Pharmacists AWP average wholesale price BCF Basic Core Formulary BPA blanket purchase agreement CCB calcium channel blocker CHAMPUS Civilian Health and Medical Programs of the Uniformed Services CMOP consolidated mail outpatient pharmacy COPD chronic obstructive pulmonary disease COX-2 cyclooxygenase-2

OCR for page 218
DESCRIPTION AND ANALYSIS OF THE VA National Formulary DAV Disabled American Veterans DESI drug efficacy study implementation DOD Department of Defense DUR drug utilization review FDA Food and Drug Administration FSS Federal Supply Schedule GAO General Accounting Office H2R histamine2 receptor 5-HT3 5-hydroxytryptamine HCFA Health Care Financing Administration HCTZ hydrochlorothiazide HMG-CoA RI hydroxymethylglutaryl-coenzyme A reductase inhibitor HMO health maintenance organization ICD-9 International Classification of Diseases, Ninth Edition IOM Institute of Medicine IPA Independent practice association IV intravenous JCAH, JCAHO Joint Commission on Accreditation of Hospitals, now Joint Commission on Accreditation of Healthcare Organizations MAP Medical Advisory Panel MCO managed care organization MTF military treatment facility NAC National Acquisition Center NCQA National Committee for Quality Assurance NDAA National Defense Authorization Act NPC National Pharmaceutical Council NRC National Research Council NSAID nonsteroidal anti-inflammatory drug OBRA Omnibus Budget Reconciliation Act OTC over the counter 1P FDA priority (drug) P&T pharmacy and therapeutics PBM pharmacy benefits management organization PVA Paralyzed Veterans of America RFP request for proposal

OCR for page 219
DESCRIPTION AND ANALYSIS OF THE VA National Formulary SSA Social Security Administration SSI Supplemental Security Income SSRI selective serotonin reuptake inhibitor TANF Temporary Assistance for Needy Families UM utilization management USP U.S. Pharmacopoeia VA Department of Veterans Affairs VFW Veterans of Foreign Wars VHA Veterans Health Administration VISN Veterans Integrated Service Network VSO veterans service organization

OCR for page 220
DESCRIPTION AND ANALYSIS OF THE VA National Formulary This page in the original is blank.

Representative terms from entire chapter:

adverse drug